Contec Medical Systems Co.,Ltd (SHE:300869)
China flag China · Delayed Price · Currency is CNY
15.63
-0.20 (-1.26%)
Jan 20, 2026, 3:04 PM CST

SHE:300869 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2015 - 2019
Operating Revenue
486.18476.07742.65708.68904.841,396
Upgrade
Other Revenue
3.733.734.253.433.874.79
Upgrade
489.91479.81746.9712.11908.711,401
Upgrade
Revenue Growth (YoY)
5.68%-35.76%4.88%-21.63%-35.15%261.84%
Upgrade
Cost of Revenue
344.99356.53359.82382.12476.88591.54
Upgrade
Gross Profit
144.92123.27387.08330431.83809.69
Upgrade
Selling, General & Admin
148.6125.28155.58122.495.5392.05
Upgrade
Research & Development
90.8105.16110.693.2566.0648.74
Upgrade
Other Operating Expenses
0.273.42-14.443.78-2.84-9.23
Upgrade
Operating Expenses
240.04235.3250.71221.45159.13132.61
Upgrade
Operating Income
-95.12-112.03136.38108.55272.7677.08
Upgrade
Interest Expense
-35.3-35.3-45.1-19.08-2.86-2.42
Upgrade
Interest & Investment Income
60.971.0692.6592.2368.6434.79
Upgrade
Currency Exchange Gain (Loss)
6.666.66-2.95-13.3160.92-13.73
Upgrade
Other Non Operating Income (Expenses)
-2.62-1.96-2.23-1.5-0.94-1.52
Upgrade
EBT Excluding Unusual Items
-65.48-71.58178.75166.89398.45694.2
Upgrade
Gain (Loss) on Sale of Investments
41.592.0246.64--
Upgrade
Gain (Loss) on Sale of Assets
0.010.17-0.07-0.26-0.04-0
Upgrade
Asset Writedown
-9.65-0.25--0.01-0.02-0
Upgrade
Other Unusual Items
-3.81-3.815.426.149.6121.27
Upgrade
Pretax Income
-74.93-73.89186.13219.39407.99715.47
Upgrade
Income Tax Expense
3.474.0220.3623.1955.64102.08
Upgrade
Net Income
-78.41-77.9165.77196.2352.35613.4
Upgrade
Net Income to Common
-78.41-77.9165.77196.2352.35613.4
Upgrade
Net Income Growth
---15.51%-44.32%-42.56%731.37%
Upgrade
Shares Outstanding (Basic)
409410404400402374
Upgrade
Shares Outstanding (Diluted)
409410414409402374
Upgrade
Shares Change (YoY)
1.11%-1.06%1.39%1.73%7.43%1.39%
Upgrade
EPS (Basic)
-0.19-0.190.410.490.881.64
Upgrade
EPS (Diluted)
-0.19-0.190.400.480.881.64
Upgrade
EPS Growth
---16.67%-45.26%-46.53%720.00%
Upgrade
Free Cash Flow
-3.347.88150.2822.21-101.66509.06
Upgrade
Free Cash Flow Per Share
-0.010.020.360.05-0.251.36
Upgrade
Dividend Per Share
0.2500.2500.3000.1250.3000.250
Upgrade
Dividend Growth
-16.67%-16.67%140.00%-58.33%20.00%-
Upgrade
Gross Margin
29.58%25.69%51.82%46.34%47.52%57.78%
Upgrade
Operating Margin
-19.42%-23.35%18.26%15.24%30.01%48.32%
Upgrade
Profit Margin
-16.00%-16.24%22.19%27.55%38.77%43.78%
Upgrade
Free Cash Flow Margin
-0.68%1.64%20.12%3.12%-11.19%36.33%
Upgrade
EBITDA
-68.8-86.04161.92127.51290.34692.25
Upgrade
EBITDA Margin
-14.04%-17.93%21.68%17.91%31.95%49.40%
Upgrade
D&A For EBITDA
26.3325.9925.5418.9617.6415.17
Upgrade
EBIT
-95.12-112.03136.38108.55272.7677.08
Upgrade
EBIT Margin
-19.42%-23.35%18.26%15.24%30.01%48.32%
Upgrade
Effective Tax Rate
--10.94%10.57%13.64%14.27%
Upgrade
Revenue as Reported
489.91479.81746.9712.11-1,401
Upgrade
Advertising Expenses
-7.768.323.86.212.26
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.